Why DermTech Stock Is Soaring Today

1 min read

Shares of DermTech (NASDAQ: DMTK) were soaring 25.4% higher as of 10:57 a.m. EST on Wednesday. The impressive jump came after the company announced that Geisinger Health System issued a positive medical benefit policy for the DermTech Pigmented Lesion Assay (PLA), a non-invasive genomic test for the early detection of melanoma.

A positive coverage decision from a major health plan such as Geisinger should pave the way for DermTech’s sales to grow. Investors are understandably excited about today’s news.

Image source: Getty Images.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Appian Stock Surged 295% in 2020: Is It a Buy for 2021?

Next Story

The U.K. Authorizes AstraZeneca’s Coronavirus Vaccine for Emergency Supply

Latest from Blog